Logo image of CMBT

CMB TECH NV (CMBT) Stock Fundamental Analysis

NYSE:CMBT - New York Stock Exchange, Inc. - BE0003816338 - Common Stock - Currency: USD

9.55  +0.04 (+0.42%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CMBT. CMBT was compared to 212 industry peers in the Oil, Gas & Consumable Fuels industry. While CMBT belongs to the best of the industry regarding profitability, there are concerns on its financial health. CMBT has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

CMBT had positive earnings in the past year.
CMBT had a positive operating cash flow in the past year.
Of the past 5 years CMBT 4 years were profitable.
CMBT had a positive operating cash flow in 4 of the past 5 years.
CMBT Yearly Net Income VS EBIT VS OCF VS FCFCMBT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M

1.2 Ratios

The Return On Assets of CMBT (37.49%) is better than 96.23% of its industry peers.
CMBT has a better Return On Equity (122.80%) than 96.70% of its industry peers.
With an excellent Return On Invested Capital value of 12.31%, CMBT belongs to the best of the industry, outperforming 81.60% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CMBT is significantly below the industry average of 25.75%.
The 3 year average ROIC (9.43%) for CMBT is below the current ROIC(12.31%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 37.49%
ROE 122.8%
ROIC 12.31%
ROA(3y)17.5%
ROA(5y)11.27%
ROE(3y)39.6%
ROE(5y)24.4%
ROIC(3y)9.43%
ROIC(5y)N/A
CMBT Yearly ROA, ROE, ROICCMBT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

1.3 Margins

CMBT's Profit Margin of 104.40% is amongst the best of the industry. CMBT outperforms 100.00% of its industry peers.
In the last couple of years the Profit Margin of CMBT has grown nicely.
CMBT has a better Operating Margin (39.03%) than 82.55% of its industry peers.
In the last couple of years the Operating Margin of CMBT has grown nicely.
Looking at the Gross Margin, with a value of 60.19%, CMBT is in the better half of the industry, outperforming 64.62% of the companies in the same industry.
In the last couple of years the Gross Margin of CMBT has remained more or less at the same level.
Industry RankSector Rank
OM 39.03%
PM (TTM) 104.4%
GM 60.19%
OM growth 3YN/A
OM growth 5Y14.72%
PM growth 3YN/A
PM growth 5Y49.82%
GM growth 3Y46.27%
GM growth 5Y-0.15%
CMBT Yearly Profit, Operating, Gross MarginsCMBT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CMBT is still creating some value.
The number of shares outstanding for CMBT has been reduced compared to 1 year ago.
CMBT has less shares outstanding than it did 5 years ago.
The debt/assets ratio for CMBT is higher compared to a year ago.
CMBT Yearly Shares OutstandingCMBT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
CMBT Yearly Total Debt VS Total AssetsCMBT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

Based on the Altman-Z score of 1.54, we must say that CMBT is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.54, CMBT perfoms like the industry average, outperforming 58.02% of the companies in the same industry.
CMBT has a Debt/Equity ratio of 1.94. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of CMBT (1.94) is worse than 81.60% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.94
Debt/FCF N/A
Altman-Z 1.54
ROIC/WACC1.63
WACC7.57%
CMBT Yearly LT Debt VS Equity VS FCFCMBT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

2.3 Liquidity

CMBT has a Current Ratio of 0.78. This is a bad value and indicates that CMBT is not financially healthy enough and could expect problems in meeting its short term obligations.
CMBT's Current ratio of 0.78 is on the low side compared to the rest of the industry. CMBT is outperformed by 70.28% of its industry peers.
A Quick Ratio of 0.71 indicates that CMBT may have some problems paying its short term obligations.
CMBT's Quick ratio of 0.71 is on the low side compared to the rest of the industry. CMBT is outperformed by 67.45% of its industry peers.
Industry RankSector Rank
Current Ratio 0.78
Quick Ratio 0.71
CMBT Yearly Current Assets VS Current LiabilitesCMBT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

4

3. Growth

3.1 Past

The earnings per share for CMBT have decreased strongly by -13.35% in the last year.
The Earnings Per Share has been growing by 43.41% on average over the past years. This is a very strong growth
CMBT shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -24.33%.
The Revenue has been growing slightly by 0.55% on average over the past years.
EPS 1Y (TTM)-13.35%
EPS 3YN/A
EPS 5Y43.41%
EPS Q2Q%-94.58%
Revenue 1Y (TTM)-24.33%
Revenue growth 3Y30.84%
Revenue growth 5Y0.55%
Sales Q2Q%-58.68%

3.2 Future

The Earnings Per Share is expected to decrease by -29.06% on average over the next years. This is quite bad
Based on estimates for the next years, CMBT will show a quite strong growth in Revenue. The Revenue will grow by 9.37% on average per year.
EPS Next Y-69.07%
EPS Next 2Y-32.88%
EPS Next 3Y-29.06%
EPS Next 5YN/A
Revenue Next Year7.15%
Revenue Next 2Y15.37%
Revenue Next 3Y9.37%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CMBT Yearly Revenue VS EstimatesCMBT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
CMBT Yearly EPS VS EstimatesCMBT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 2.58, the valuation of CMBT can be described as very cheap.
Compared to the rest of the industry, the Price/Earnings ratio of CMBT indicates a rather cheap valuation: CMBT is cheaper than 98.11% of the companies listed in the same industry.
CMBT is valuated cheaply when we compare the Price/Earnings ratio to 28.88, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 8.34, the valuation of CMBT can be described as very reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CMBT indicates a somewhat cheap valuation: CMBT is cheaper than 70.28% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of CMBT to the average of the S&P500 Index (21.20), we can say CMBT is valued rather cheaply.
Industry RankSector Rank
PE 2.58
Fwd PE 8.34
CMBT Price Earnings VS Forward Price EarningsCMBT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CMBT is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.55
CMBT Per share dataCMBT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

CMBT has an outstanding profitability rating, which may justify a higher PE ratio.
A cheap valuation may be justified as CMBT's earnings are expected to decrease with -29.06% in the coming years.
PEG (NY)N/A
PEG (5Y)0.06
EPS Next 2Y-32.88%
EPS Next 3Y-29.06%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 62.58%, CMBT is a good candidate for dividend investing.
CMBT's Dividend Yield is rather good when compared to the industry average which is at 7.31. CMBT pays more dividend than 100.00% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.45, CMBT pays a better dividend.
Industry RankSector Rank
Dividend Yield 62.58%

5.2 History

On average, the dividend of CMBT grows each year by 116.35%, which is quite nice.
CMBT has been paying a dividend for over 5 years, so it has already some track record.
CMBT has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)116.35%
Div Incr Years2
Div Non Decr Years3
CMBT Yearly Dividends per shareCMBT Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 1 2 3 4 5

5.3 Sustainability

CMBT pays out 76.95% of its income as dividend. This is not a sustainable payout ratio.
CMBT's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP76.95%
EPS Next 2Y-32.88%
EPS Next 3Y-29.06%
CMBT Yearly Income VS Free CF VS DividendCMBT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B
CMBT Dividend Payout.CMBT Dividend Payout, showing the Payout Ratio.CMBT Dividend Payout.PayoutRetained Earnings

CMB TECH NV

NYSE:CMBT (5/1/2025, 10:29:46 AM)

9.55

+0.04 (+0.42%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)02-27 2025-02-27/bmo
Earnings (Next)05-14 2025-05-14/bmo
Inst Owners1.58%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.10B
Analysts76.67
Price Target13.65 (42.93%)
Short Float %2.26%
Short Ratio3.39
Dividend
Industry RankSector Rank
Dividend Yield 62.58%
Yearly Dividend5.68
Dividend Growth(5Y)116.35%
DP76.95%
Div Incr Years2
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-26.64%
Min EPS beat(2)-49.61%
Max EPS beat(2)-3.67%
EPS beat(4)2
Avg EPS beat(4)129.78%
Min EPS beat(4)-49.61%
Max EPS beat(4)330.29%
EPS beat(8)6
Avg EPS beat(8)107.97%
EPS beat(12)9
Avg EPS beat(12)83.68%
EPS beat(16)11
Avg EPS beat(16)63.65%
Revenue beat(2)2
Avg Revenue beat(2)8.74%
Min Revenue beat(2)6.27%
Max Revenue beat(2)11.21%
Revenue beat(4)3
Avg Revenue beat(4)7.71%
Min Revenue beat(4)-1.97%
Max Revenue beat(4)15.33%
Revenue beat(8)7
Avg Revenue beat(8)31.11%
Revenue beat(12)11
Avg Revenue beat(12)39.61%
Revenue beat(16)15
Avg Revenue beat(16)45.07%
PT rev (1m)1.23%
PT rev (3m)-19.42%
EPS NQ rev (1m)0%
EPS NQ rev (3m)68.46%
EPS NY rev (1m)0%
EPS NY rev (3m)-27.55%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.55%
Revenue NY rev (1m)-1.72%
Revenue NY rev (3m)-11.57%
Valuation
Industry RankSector Rank
PE 2.58
Fwd PE 8.34
P/S 1.5
P/FCF N/A
P/OCF 4.58
P/B 1.76
P/tB 1.79
EV/EBITDA 6.55
EPS(TTM)3.7
EY38.74%
EPS(NY)1.14
Fwd EY11.98%
FCF(TTM)-3.01
FCFYN/A
OCF(TTM)2.09
OCFY21.85%
SpS6.37
BVpS5.42
TBVpS5.35
PEG (NY)N/A
PEG (5Y)0.06
Profitability
Industry RankSector Rank
ROA 37.49%
ROE 122.8%
ROCE 15.59%
ROIC 12.31%
ROICexc 12.45%
ROICexgc 12.51%
OM 39.03%
PM (TTM) 104.4%
GM 60.19%
FCFM N/A
ROA(3y)17.5%
ROA(5y)11.27%
ROE(3y)39.6%
ROE(5y)24.4%
ROIC(3y)9.43%
ROIC(5y)N/A
ROICexc(3y)10.41%
ROICexc(5y)N/A
ROICexgc(3y)10.46%
ROICexgc(5y)N/A
ROCE(3y)11.93%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y15.98%
ROICexc growth 3YN/A
ROICexc growth 5Y15.87%
OM growth 3YN/A
OM growth 5Y14.72%
PM growth 3YN/A
PM growth 5Y49.82%
GM growth 3Y46.27%
GM growth 5Y-0.15%
F-Score4
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 1.94
Debt/FCF N/A
Debt/EBITDA 3.25
Cap/Depr 675.47%
Cap/Sales 79.96%
Interest Coverage 5.02
Cash Conversion 64.34%
Profit Quality N/A
Current Ratio 0.78
Quick Ratio 0.71
Altman-Z 1.54
F-Score4
WACC7.57%
ROIC/WACC1.63
Cap/Depr(3y)357.13%
Cap/Depr(5y)252.34%
Cap/Sales(3y)69.97%
Cap/Sales(5y)65.4%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-13.35%
EPS 3YN/A
EPS 5Y43.41%
EPS Q2Q%-94.58%
EPS Next Y-69.07%
EPS Next 2Y-32.88%
EPS Next 3Y-29.06%
EPS Next 5YN/A
Revenue 1Y (TTM)-24.33%
Revenue growth 3Y30.84%
Revenue growth 5Y0.55%
Sales Q2Q%-58.68%
Revenue Next Year7.15%
Revenue Next 2Y15.37%
Revenue Next 3Y9.37%
Revenue Next 5YN/A
EBIT growth 1Y-39.07%
EBIT growth 3YN/A
EBIT growth 5Y15.35%
EBIT Next Year60.32%
EBIT Next 3Y20.22%
EBIT Next 5YN/A
FCF growth 1Y-232.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-45.18%
OCF growth 3YN/A
OCF growth 5Y11.04%